+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Olanzapine"

Olanzapine Global Market Report 2024 - Product Thumbnail Image

Olanzapine Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Bipolar Disorder Therapeutics Global Market Report 2024 - Product Thumbnail Image

Bipolar Disorder Therapeutics Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
From
LYBALVI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LYBALVI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
From
Bipolar Depression - Pipeline Insight, 2024 - Product Thumbnail Image

Bipolar Depression - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Schizophrenia - Pipeline Insight, 2024 - Product Thumbnail Image

Schizophrenia - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 80 Pages
  • Global
From
Anorexia Nervosa - Pipeline Insight, 2024 - Product Thumbnail Image

Anorexia Nervosa - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 60 Pages
  • Global
From
Dopamine D1 receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Dopamine D1 receptor antagonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
Mental Illness Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Mental Illness Drugs Industry Forecasts - China Focus

  • Report
  • November 2023
  • 92 Pages
  • China
From
From
From
LYBALVI Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LYBALVI Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Disease Analysis: Schizophrenia - Product Thumbnail Image

Disease Analysis: Schizophrenia

  • Report
  • March 2021
  • 101 Pages
  • Global
Loading Indicator

Olanzapine is a medication used to treat mental health conditions such as schizophrenia, bipolar disorder, and depression. It is a member of the atypical antipsychotic class of drugs, which are used to treat the symptoms of mental health conditions. Olanzapine works by blocking certain receptors in the brain, which helps to reduce the symptoms of mental health conditions. It is also used to treat agitation and aggression in people with dementia. Olanzapine is a widely used medication in the Central Nervous System (CNS) drug market. It is used to treat a variety of mental health conditions, and is often prescribed as a first-line treatment for schizophrenia. It is also used to treat other mental health conditions, such as bipolar disorder and depression. Olanzapine is generally well-tolerated, and has fewer side effects than other antipsychotic medications. Some companies in the Olanzapine market include Eli Lilly, Pfizer, Novartis, and Teva Pharmaceuticals. Show Less Read more